MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis
An emerging but less explored shared pathophysiology across microbiota-gut-brain axis disorders is aberrant miRNA expression, which may represent novel therapeutic targets. miRNAs are small, endogenous non-coding RNAs that are important transcriptional repressors of gene expression. Most importantly...
Saved in:
Main Authors: | Neha Datta (Author), Charlotte Johnson (Author), Dina Kao (Author), Pratik Gurnani (Author), Cameron Alexander (Author), Christos Polytarchou (Author), Tanya M. Monaghan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis
by: Anand Singh, et al.
Published: (2021) -
Transforming growth factor-beta and microRNA-21, microRNA-29b, microRNA-92, and microRNA-129 in systemic sclerosis patients: a case-control study
by: Mohammed Hassan Mohammed, et al.
Published: (2022) -
Nucleotide Modification Alters MicroRNA-Dependent Silencing of MicroRNA Switches
by: John Lockhart, et al.
Published: (2019) -
MicroRNA Signaling
Published: (2020) -
MicroRNA and Cancer
Published: (2022)